Category - cumshot
breast cancer (invasive nonmetastatic) treatment regimens. To help decide which women with stage ii hormone receptor-positive, her2-negative breast cancer will benefit from chemotherapy, a gene panel test such as oncotype dx may be done on the tumor sample. The drugs used will depend on the womans age, as well as tumor test results, including hormone-receptor status and her2 status. Treatment for colon cancer is based largely on the stage (extent) of the cancer, but other factors can also be important. People with colon cancers that have not spread to distant sites usually have surgery as the main or first treatment. Chemotherapy may also be used after surgery (called adjuvant treatment). Recommendationsall patients with stage ii breast cancer should be considered for systemic adjuvant therapy. Adjuvant chemotherapy in node-positive breast cancer improves disease-free and overall survival by 24 and 15, respectively. stage ii is divided into subcategories known as iia and iib. Food and drug administration (fda) approved taxotere for the treatment of early stage breast cancer. Dose-dense chemotherapy ac, tac, cmf, and other chemotherapy regimens are typically administered every three weeks. Dose-dense chemotherapy refers to chemotherapy treatment that is administered more frequently. Stage ii breast cancer is further subdivided into stages iia and iib. Patients classified as having stage iia breast cancer include those with t0-1, n1, and t2, n0 disease. Stage iib breast cancer includes patients with t2, n1, and t3, n0 disease. Therefore, this patient population is more heterogeneous than are the populations with stages 0. abraham j, robidoux a, tan ar, limentani s, sturtz k, shalaby i, et al. Phase ii randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced her2-negative breast cancer nsabp foundation study fb-9. stage 0, i, ii or iiia (t3n1m0) in the united states and other developed nations where screening is performed, most patients present with localized breast cancer that is detected by a screening mammogram less commonly, patients present with a palpable mass that is either self-detected or detected by a health care provider.